Marx, N., & Floege, J. (2021). Dapagliflozin, advanced chronic kidney disease, and mortality: New insights from the DAPA-CKD trial. Eur Heart J.
Chicago Style aipamenaMarx, Nikolaus, and Jürgen Floege. "Dapagliflozin, Advanced Chronic Kidney Disease, and Mortality: New Insights From the DAPA-CKD Trial." Eur Heart J 2021.
MLA aipamenaMarx, Nikolaus, and Jürgen Floege. "Dapagliflozin, Advanced Chronic Kidney Disease, and Mortality: New Insights From the DAPA-CKD Trial." Eur Heart J 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.